Anatomic Pathology Market Size (2024 - 2029)

Anatomic Pathology Market Analysis

The anatomical pathology market is expected to register a CAGR of 6.5% during the forecast period.

The COVID-19 outbreak impacted every aspect of the diagnostics industry, including the anatomic pathology market. During the initial pandemic, the number of patient visits to hospitals reduced significantly despite emergency services being available in hospitals. For instance, according to an article published by BMC Health Services Research in February 2022, a study was conducted in the Netherlands, which showed that the initial COVID-19 pandemic significantly impacted diagnostic pathology or anatomic pathology in the country. Thus, the COVID-19 pandemic significantly impacted the market initially. However, as the pandemic has subsided, cancer diagnosis procedures are taking place normally. Hence, the studied market is expected to have stable growth during the forecast period of the study.

Factors that are driving the market growth are the high incidence of cancer and other target diseases, the growing focus on personalized medicine, and the high usage of advanced pathology equipment.

The rising prevalence of cancer is a major factor driving the market growth, as anatomic pathology is used for the diagnosis of these diseases. For instance, according to the data published by the Spanish Network of Cancer Registries in January 2021, an estimated 0.28 million new cases of cancer were expected in Spain in 2021, out of which 43.6 thousand colorectal cancer cases, 35.8 thousand prostate cancer cases, and 33.4 thousand breast cancer cases were expected.

Moreover, according to the data published by the National Cancer Center Japan in June 2022, an estimated 1,019,000 new cases of cancer were expected in Japan in 2022, out of which 158,200 were new cases of colon/rectum cancer, 132,100 cases of stomach cancer, 128,800 cases of lung/trachea cancer, 96,400 cases of prostate cancer, and 95,000 cases of breast cancer. Thus, the greater incidence of cancers has increased the demand for various anatomic pathology products for the diagnosis of cancers.

Additionally, the rising developments by various organizations are also expected to enhance market growth. For instance, in October 2022, pathologists from Europe, Japan, and the United States jointly debuted the Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory.

Thus, the aforementioned factors, such as the rising prevalence of cancer, increasing demand for personalized medicines, and the rising developments by various organizations, are expected to enhance the market growth. However, stringent government regulations pertaining to anatomic pathology and the lack of skilled professionals are expected to hinder market growth.

Anatomic Pathology Industry Segmentation

As per the scope of the report, anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic, and molecular examination of organs and tissues. Anatomic pathology involves the visualization of human tissue under a microscope for proper diagnosis of a disease or a pathological condition. Microscopic examination of tissue samples with the help of one or more stains is a standard procedure performed in anatomic pathology. The anatomic pathology market is segmented by products & services (instruments, consumables, and services), applications (disease diagnosis, drug discovery and development, and other applications), end users (hospitals, research laboratories, diagnostic laboratories, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.